Lv41
610 积分 2023-03-07 加入
FRI0296 Kzr-616, a selective inhibitor of the immunoproteasome, blocks the disease progression in multiple models of systemic lupus erythematosus (SLE)
10天前
已完结
Differential expression of mucosal addressin cell adhesion molecule‐1 (MAdCAM‐1) in ulcerative colitis and Crohn's disease
23天前
已完结
Dual Biologic or Small Molecule Therapy for Treatment of Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
2个月前
已完结
B cell-driven immune remodeling in inflammatory bowel disease: links to pathogenesis and therapeutic failure
2个月前
已完结
Exploring the next generation of antibody–drug conjugates
3个月前
已完结
Screening Ultra-Large Encoded Compound Libraries Leads to Novel Protein–Ligand Interactions and High Selectivity
3个月前
已完结
Chasing molecular glue degraders: screening approaches
3个月前
已完结
Molecular Glue Discovery: Current and Future Approaches
3个月前
已完结
Routes to molecular glue degrader discovery
3个月前
已完结
The New Frontier: Merging Molecular Glue Degrader and Antibody–Drug Conjugate Modalities To Overcome Strategic Challenges
3个月前
已完结
皖公网安备34019202002308
